MR Related Analyst Ratings
-
Goldman Sachs Upgraded Mindray Medical (MR) to Conviction Buy
-
Piper Jaffray Upgrades Mindray Medical (MR) to Overweight; Raises Estimates and Price Target
-
Soleil Securities Initiates Coverage on Mindray Medical (MR) with a Buy
-
Susquehanna Initiates Coverage on Mindray Medical (MR); Significant Upside to Valuation
-
Piper Jaffray Maintains a 'Neutral' on Mindray Medical (MR); Raises Prices Target & 2009 Estimates
-
Goldman Sachs Downgrades Mindray Medical (MR) to Neutral
-
Credit Suisse Downgrades Mindray Medical (MR) to Neutral
-
Maxim Starts Mindray Medical (MR) with a Buy
-
Morgan Stanley Initiates Coverage on Mindray Medical (MR) with an Overweight
-
S&P Equity Research Downgrades Mindray Medical (MR) to Buy
-
S&P Equity Research Reiterates 'Strong Buy' on Mindray Medical (MR)
-
Piper Jaffray Bullish on Mindray Medical (MR)
-
Citigroup Starts Mindray Medical (MR) at Buy
-
Bear Stearns Initiates Coverage on Mindray Medical (MR) with an Outperform
-
Piper Jaffray Adds Mindray Medical (MR) to the Alpha List
-
Piper Jaffray upgrades Mindray Medical (MR) to Outperform
-
Brean Murray Starts Mindray Medical (MR) at Buy
-
UBS upgrades Mindray Medical International Ltd. (MR) to Buy
Back to MR Stock Lookup
